Article

Ophthalmology could lead 'next movement of value for health care,' says keynote speaker

The specialty of ophthalmology is "in the cross hairs of the demographic transition and the demand for services and the cost of care in the United States" occurring as the aging of the large baby boomer population necessitates increased amounts of clinical care. By rising to the challenge, however, the profession can serve as an example to other specialties, said Harvey V. Fineberg, MD, PhD, in his keynote address during the opening session of the American Academy of Ophthalmology/European Society of Ophthalmology joint meeting.

The specialty of ophthalmology is "in the cross hairs of thedemographic transition and the demand for services and the costof care in the United States" occurring as the aging of the largebaby boomer population necessitates increased amounts of clinicalcare. By rising to the challenge, however, the profession canserve as an example to other specialties, said Harvey V.Fineberg, MD, PhD, in his keynote address during the openingsession of the American Academy of Ophthalmology/European Societyof Ophthalmology joint meeting.

Dr. Fineberg, president of the nonprofit Institute of Medicine inWashington, DC, said that the times present a chance forphysicians, individually and collectively, "to take much greaterinitiative. ...by relentlessly focusing on increasing the valueof what we do for patients. . . [and] improving the benefits andthe outcomes and diminishing the costs" associated with healthcare.

Five keys to success in this effort, he said, include:

  • Innovation within a system that has a renewed investmentin research.
  • Attention to organization and an embrace of other eye-careprofessionals in the delivery of care in appropriate ways.
  • Evaluation, exemplified in evidence-based medicine.
  • Much greater emphasis on quality enhancement.
  • A commitment to continuing education.

"I believe that the profession has an opportunity and achallenge. It has an opportunity because if it takes theinitiative to move toward a system of value in health care, wecan dissolve the tired arguments about cost, we can go beyond thelimited aims of more benefits, and we can produce for theAmerican public and, indeed, for citizens of the world, healthcare that is truly what they deserve," Dr. Fineberg said." Ibelieve ophthalmology is powerfully positioned to be the exemplarand leader in the next movement of value for health care."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.